Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Subpart IVC - Clinical – Vascular
from Part IV - Clinical
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 158 - 179Publisher: Cambridge University PressPrint publication year: 2017
References
References
White, R. The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 suppl 1):I 4–8.CrossRefGoogle ScholarPubMed
Beckman, MG, Hooper, WC, Critchley, SE, et al. Venous thromboembolism: a public health concern. AM J Prev Med. 2010 Apr; 38 (4Suppl):S495–501.CrossRefGoogle ScholarPubMed
Spyropoulos, AC, Lin, J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007 Jul-Aug; 13(6): 475– 486.Google ScholarPubMed
Hirsh, J, Guyatt, G, Albers, GW, et al. American College of Chest Physicians. Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence based clinical practice guidelines, 9th ed. Chest. 2008; 133(6 suppl): 110s–112s.CrossRefGoogle Scholar
Cushman, M, Tsai, AW, White, RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004 Jul 1; 117(1):19–25.CrossRefGoogle ScholarPubMed
Labropoulos, N, Jen, J, Jen, H, et al. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg. 2010 Apr; 251(4):749–753.CrossRefGoogle ScholarPubMed
Heit, JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005 Aug; 3(8):1611–1617.CrossRefGoogle ScholarPubMed
Prandoni, P, Lensing, AWA, Cogo, A, et al. Long-term outcomes after deep venous thrombosis of the lower extremities. Vasc Med. 1998; 3(1):57–60.CrossRefGoogle ScholarPubMed
Prandoni, P, Lensing, AWA, Cogo, A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1–7.CrossRefGoogle ScholarPubMed
Kahn, SR. The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis. 2006 Feb; 21(1): 41–48.CrossRefGoogle ScholarPubMed
Roumen-Klappe, EM, Janssen, MC, Van Rossum, J, et al. Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. J Thromb Haemost. 2009 Apr; 7(4): 582–587.CrossRefGoogle ScholarPubMed
Anderson, FA Jr, Wheeler, HB, Goldberg, RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991May; 151(5): 933–938.CrossRefGoogle ScholarPubMed
Hull, R, Hirsh, J, Sackett, DL, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation. 1981 Sep; 64(3):622–625.CrossRefGoogle ScholarPubMed
Wells, PS, Owen, C, Doucette, S, et al. Does this patient have deep vein thrombosis? JAMA. 2006 Jan 11; 295(2):199–207.CrossRefGoogle ScholarPubMed
Bates, SM, Jaeschke, R, Stevens, SM, et al. Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb 141(2 Suppl):e351S–418S.CrossRefGoogle ScholarPubMed
Prins, M, Lensing, AW, Bauersachs, R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the Einstein- DVT and PE randomized Studies. Thromb J. 2013 Sep 20:11(1).CrossRefGoogle ScholarPubMed
Burness, CB, Perry, C. Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism. Drugs. 2014 Feb; 74(2):243–262.CrossRefGoogle ScholarPubMed
Einstein Investigators, Bauersachs, R, Berkowitz, SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010 Dec23; 363(26): 2499–2510.Google ScholarPubMed
Einstein-PE Investigators, Buller, HR, Prins, MH, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 Apr 5; 366(14): 1287–1297.Google ScholarPubMed
Kearon, C, Akl, EA, Ornealas, J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016 Feb1; 149(2):315–352.CrossRefGoogle ScholarPubMed
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb; 14(2 suppl):e419s–494s.Google Scholar
Hovanessian, HC. New-generation anticoagulants: the low molecular weight heparins. Ann Emerg Med. 1999 Dec; 34(6):768–779.CrossRefGoogle ScholarPubMed
Bossuyt, PM, Van den Belt, AG, Prins, MH. Out-of-hospital treatment of venous thrombosis: socioeconomic aspects and patients’ quality of life. Hemostasis. 1998; 28 Suppl 3:100–107.Google ScholarPubMed
References
Silverstein, MD, Heit, JA, Mohr, DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158(6): 585–593.CrossRefGoogle ScholarPubMed
White, RH. The epidemiology of venous thromboembolism. Circulation 2003; 107(23 Suppl 1): I4–8.CrossRefGoogle ScholarPubMed
Kearon, C. Natural history of venous thromboembolism. Circulation 2003; 107(23 Suppl 1): I22–30.CrossRefGoogle ScholarPubMed
Dalen, JE, Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002; 122(4): 1440–1456.CrossRefGoogle ScholarPubMed
Jakobsson, C, Jimenez, D, Gomez, V, et al. Validation of a clinical algorithm to identify low-risk patients with pulmonary embolism. J Thromb Haemost 2010; 8(6): 1242–1247.CrossRefGoogle ScholarPubMed
Jimenez, D, Yusen, RD, Otero, R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132(1): 24–30.CrossRefGoogle ScholarPubMed
Aujesky, D, Perrier, A, Roy, PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261(6): 597–604.CrossRefGoogle ScholarPubMed
Janjua, M, Badshah, A, Matta, F, et al. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost 2008; 100(5): 756–761.CrossRefGoogle ScholarPubMed
Agterof, MJ, Schutgens, RE, Snijder, RJ, et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost 2010; 8(6): 1235–1241.CrossRefGoogle ScholarPubMed
Zondag, W, Mos, IC, Creemers-Schild, D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 2011; 9(8): 1500–1507.CrossRefGoogle ScholarPubMed
Agterof, MJ, Schutgens, RE, Moumli, N, et al. A prognostic model for short term adverse events in normotensive patients with pulmonary embolism. Am J Hematol 2011; 86(8): 646–649.CrossRefGoogle ScholarPubMed
Snow, V, Quseem, A, Barry, P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007; 146(3): 204–210.CrossRefGoogle ScholarPubMed
Torbicki, A, Perrier, A, Konstantinides, S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29(18): 2276–2315.Google ScholarPubMed
Aujesky, D, Stone, RA, Kim, S, et al. Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Arch Intern Med 2008; 168(7): 706–712.CrossRefGoogle ScholarPubMed
Bledsoe, J, Hamilton, D, Bess, E, et al. Treatment of low-risk pulmonary embolism patients in a chest pain unit. Crit Pathw Cardiol 2010; 9(4): 212–215.CrossRefGoogle Scholar
Ceriani, E, Combescure, C, Le Gal, G, et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost 2010; 8(5): 957–970.CrossRefGoogle ScholarPubMed
Douma, RA, Mos, IC, Erkens, PM, et al. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med 2011; 154(11): 709–718.CrossRefGoogle ScholarPubMed
Righini, M, Perrier, A, DeMoerloose, P, et al. D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost 2008; 6(7): 1059–1071.CrossRefGoogle ScholarPubMed
van Belle, A, Buller, HR, Huisman, MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295(2): 172–179.Google ScholarPubMed
Qaseem, A, Snow, V, Barry, P, et al. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2007; 146(6): 454–458.CrossRefGoogle ScholarPubMed
The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263(20): 2753–2759.CrossRefGoogle Scholar
Le Gal, G, Righini, M, Boehlen, F, et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients. Thromb Haemost 2006; 95(6): 963–966.Google ScholarPubMed
Lankeit, M, Konstantinides, S. Mortality risk assessment and the role of thrombolysis in pulmonary embolism. Clin Chest Med 2010; 31(4): 759–769.CrossRefGoogle ScholarPubMed
Becattini, C, Vedovati, MC, Agnelli, G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116(4): 427–433.CrossRefGoogle ScholarPubMed
Wicki, J, Perrier, A, Pemeger, TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 2000; 84(4): 548–552.CrossRefGoogle ScholarPubMed
Uresandi, F, Otero, R, Cayuela, A, et al. A clinical prediction rule for identifying short-term risk of adverse events in patients with pulmonary thromboembolism. Arch Bronconeumol 2007; 43(11): 617–622.CrossRefGoogle ScholarPubMed
Murugappan, M, Johnson, JA, Gage, BF, et al. Home Management Exclusion (HOME) criteria for initial treatment of acute pulmonary embolism. Am J Respir Crit Care Med 2008; 177: A182.Google Scholar
Nendaz, MR, Bandelier, P, Aujesky, D, et al. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost 2004; 91(6): 1232–1236.Google ScholarPubMed
Aujesky, D, LeManach, CD, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27(4): 476–481.CrossRefGoogle Scholar
Otero, R, Jimenez, D. Pulmonary embolism at home. Eur Respir J 2008; 31(3): 686–687; author reply 687.CrossRefGoogle ScholarPubMed
Aujesky, D, Obrosky, DS, Stone, RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172(8): 1041–1046.CrossRefGoogle ScholarPubMed
Venetz, C, Jimenez, D, Mean, M, et al. A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 2011; 106(3): 423–428.CrossRefGoogle ScholarPubMed
Konstantinides, S, Torkicki, A, Agnelli, G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. European Heart Journal 2014; 35(43): 3033–3069.Google ScholarPubMed
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.CrossRefGoogle ScholarPubMed
Kearon, C, Akl, EA, Ornelas, J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149.CrossRefGoogle Scholar
FDA expands use of Xarelto to treat, reduce recurrence of blood clots. November 8, 2012; Available from: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm. (Accessed March 2016)Google Scholar
Einstein PE Investigators: Buller, HR, Prins, MH, Lensin, AW, et al. Oral rivaroxaban for the treatment of Symptomatic Pulmonary Embolism. N Engl J Med 2012; 366(14): 1287–1297.Google ScholarPubMed
Agnelli, G, Buller, HR, Cohen, A, et al. Oral Apixaban for the treatment of Acute Venous Thromboembolism. NEJM 2013; 369(9): 799–808.CrossRefGoogle ScholarPubMed
Hokusai-VTE Investigators: Buller, HR, Decousus, H, Gross, MA, et al. Edoxaban versus Warfarin for the treatment of Symptomatic Venous Thromboembolism. NEJM 2013; 369: 1406–1415.Google ScholarPubMed
Schulman, S, Kearon, C, Kakkar, AK, et al. Re-Cover Study Group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361(24): 2342–2352.CrossRefGoogle Scholar
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.CrossRefGoogle ScholarPubMed
Van Der Hulle, T, Kooiman, J, den Exter, PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis 2014; 12: 320–328.CrossRefGoogle ScholarPubMed
References
Oden, A, Fahlen, M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ, 2002. 325(7372): 1073–1075.CrossRefGoogle Scholar
Schulman, S, Beyth, RJ, Kearon, C, et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008. 133(6 Suppl): 257S–298S.CrossRefGoogle ScholarPubMed
Hylek, EM, Chang, YC, Skates, SJ, et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med, 2000. 160(11): 1612–1617.CrossRefGoogle ScholarPubMed
Cannegieter, SC,Rosendaal, FR, Wintzen, AD, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med, 1995. 333(1): 11–7.CrossRefGoogle ScholarPubMed
Chiquette, E, Amato, MG, Bussey, HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med, 1998. 158(15): 1641–1647.CrossRefGoogle ScholarPubMed
Newman, DH, Zhitomirsky, I. The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department. Ann Emerg Med, 2006. 48(2): 182–189, 189 e1.CrossRefGoogle ScholarPubMed
Atreja, A, El-Sameed, YA, Jneid, H, et al. Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations. Am J Emerg Med, 2005. 23(1): 40–44.CrossRefGoogle Scholar
Denas, G, Marzot, F, Offellie, R, et al. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. J Thromb Thrombolysis, 2009. 27(3): 340–347.CrossRefGoogle ScholarPubMed
Crowther, MA, Garcia, D, Ageno, W, et al. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study. Thromb Haemost, 2010. 104(1): 118–121.Google ScholarPubMed
Ageno, W, Gallus, G, Wittkowsky, A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): e44S–88S.CrossRefGoogle ScholarPubMed
Harrison, L, Johnston, M, Massicotte, MP, et al. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med, 1997. 126(2): 133–136.CrossRefGoogle ScholarPubMed
Ansell, J, Hirsh, J, Hylek, E, et al. Pharmacology and Management of the Vitamin K Antagonists, 8th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2008. 133(6 Suppl): 160S–198S.CrossRefGoogle ScholarPubMed
Wan, Y, Heneghan, C, Perera, R, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes, 2008. 1(2): 84–91.CrossRefGoogle ScholarPubMed
You, JJ, Singer, DE, Howard, PA, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): e531S–575S.CrossRefGoogle ScholarPubMed
Kearon, C, Akl, EA, Comerota, AJ, et al. Antithrombotic therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): e419S–494S.CrossRefGoogle ScholarPubMed
Whitlock, RP, Sun, JC, Fremes, SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): e576S–600S.CrossRefGoogle ScholarPubMed
Hylek, EM, Singer, DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med, 1994. 120(11): 897–902.CrossRefGoogle ScholarPubMed
Dahr, K, Loewen, P. The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules. Thromb Haemost, 2007. 98(5): 980–987.CrossRefGoogle Scholar
Beyth, RJ, Quinn, LM, Landefeld, CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med, 1998. 105(2): 91–99.CrossRefGoogle ScholarPubMed
Pisters, R, Lane, DA, Nieuwlaat, R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation. Chest, 2010; 138: 1093–1100.CrossRefGoogle ScholarPubMed
Lip, GY, Frison, L, Halpern, JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation. Journal of the American College of Cardiology, 2011; 57: 173–180.CrossRefGoogle ScholarPubMed
Schulman, S, Kearon, C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of Thrombosis and Haemostasis, 2005; 3:692–694.CrossRefGoogle ScholarPubMed
Guerrouij, M, Uppal, CS, Alklabi, A, et al. The clinical impact of bleeding during oral anticoagulant therapy: assessment of morbidity, mortality and post-bleed anticoagulant management. J Thromb Thrombolysis, 2011. 31(4): 419–423.CrossRefGoogle ScholarPubMed
Palareti, G, Hirsh, J, Legnani, C, et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med, 2000. 160(4): 470–478.CrossRefGoogle ScholarPubMed
Landefeld, CS, Beyth, RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med, 1993. 95(3): 315–328.CrossRefGoogle ScholarPubMed
Palareti, G, Leali, N, Coccheri, S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet, 1996. 348(9025): 423–428.CrossRefGoogle Scholar
Linkins, LA, Choi, PT, Douketis, JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med, 2003. 139(11): 893–900.CrossRefGoogle ScholarPubMed
Lousberg, TR, Witt, DM, Beall, DG, et al. Evaluation of excessive anticoagulation in a group model health maintenance organization. Arch Intern Med, 1998. 158(5): 528–534.CrossRefGoogle Scholar
Dezee, KJ, Shimeall, WT, Douglas, KM, et al. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med, 2006. 166(4): 391–397.Google ScholarPubMed
Crowther, MA, Ageno, W, Garcia, D, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med, 2009. 150(5): 293–300.CrossRefGoogle ScholarPubMed
Crowther, MA, Julian, J, McCarty, D, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet, 2000. 356(9241): 1551–1553.CrossRefGoogle ScholarPubMed
Ageno, W, Crowther, M, Steidl, L, et al. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Thromb Haemost, 2002. 88(1): 48–51.Google ScholarPubMed
Ageno, W, Garcia, D, Silingardi, M, et al. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves. J Am Coll Cardiol, 2005. 46(4): 732–733.CrossRefGoogle ScholarPubMed
Garcia, DA, Regan, S, Crowther, M, et al. The risk of hemorrhage among patients with warfarin-associated coagulopathy. J Am Coll Cardiol, 2006. 47(4): 804–808.CrossRefGoogle ScholarPubMed
Gunther, KE, Conway, G, Leibach, L, et al. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Thromb Res, 2004. 113(3–4): 205–209.CrossRefGoogle ScholarPubMed
Lubetsky, A, Yonath, H, Olchovsky, D, et al. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med, 2003. 163(20): 2469–2473.CrossRefGoogle ScholarPubMed
Crowther, MA, Donovan, D, Harrison, L, et al. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost, 1998. 79(6): 1116–1118.Google ScholarPubMed
Guyatt, GH, Akl, EA, Crowther, M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): 7S–47S.CrossRefGoogle ScholarPubMed
Fiore, LD, Scola, MA, Cantillon, CE, et al. Anaphylactoid reactions to vitamin K. J Thromb Thrombolysis, 2001. 11(2): 175–183.CrossRefGoogle ScholarPubMed
Crowther, MA, Douketis, JD, Schnurr, T, et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med, 2002. 137(4): 251–254.CrossRefGoogle ScholarPubMed
Raj, G, Kumar, R, McKinney, WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med, 1999. 159(22): 2721–2724.CrossRefGoogle ScholarPubMed
Ruff, CT, Giugliano, RP, Braunwald, E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet, 2014; 383: 955–962.CrossRefGoogle Scholar
Van Der Hulle, T, Kooiman, J, den Exter, PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 2014; 12: 320–328.CrossRefGoogle ScholarPubMed
Jackson, LR, Becker, RC. Novel oral anticoagulants: pharmacology, coagulation measures, and consideration for reversal. J Thromb Thrombolysis, 2014; 37:380–391.CrossRefGoogle ScholarPubMed
Kovacs, RJ, Flaker, GC, Saxonhouse, SJ, et al. Practical management of anticoagulation in patients with atrial fibrillation. Journal of the American College of Cardiology, 2015; 65: 1340–1360.CrossRefGoogle ScholarPubMed